Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Interventions

resiniferatoxin 1 cannabichromene 1 Transcutaneous Electric Nerve Stimulation 1 Transcranial Direct Current Stimulation 1 Tramadol 1 Therapeutic Touch 1 Telemedicine 1 Surveys and Questionnaires 1 Standard of Care 1 Spinal Cord Stimulation 1 Radiosurgery 1 Pharmacogenomic Testing 1 Patient Education as Topic 1 Pain Management 1 Oxycodone 1 Midazolam 1 Massage 1 Lidocaine 1 Laser Therapy 1 Electroacupuncture 1 Duloxetine Hydrochloride 1 Dronabinol 1 Control Groups 1 Cognitive Behavioral Therapy 1 Cannabidiol 1 Art Therapy 1 Acupuncture Therapy 1 Acupressure 1 Acetaminophen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Cancer Pain × cannabichromene × 1 year × Clear all

NCT06533657 2026-04-21

UTOPIA-1

ZYUS Life Sciences Inc.

Phase 2 Completed

Cancer Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡